Medx Health

Medx Health EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medx Health (MDX.V) as of Oct 19, 2026 is -4.53 M CAD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -2.27 M CAD — a change of 99.39% (lower).

EBITDA

-4.53 MCAD

YoY

99.39%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medx Health is 2025 -4.53 M CAD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medx Health was 2024 -2.27 M CAD. It decreases by 99.39% lower compared to the previous year.

The Medx Health EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-3.99 M CAD
Jan 1, 2019
-3.00 M CAD
Jan 1, 2020
-2.96 M CAD
Jan 1, 2021
-4.56 M CAD
Jan 1, 2022
-3.83 M CAD
Jan 1, 2023
-2.39 M CAD
Jan 1, 2024
-2.27 M CAD
Jan 1, 2025
-4.53 M CAD
The Medx Health EBITDA history
YEAREBITDAYoY
-4.53 MCAD+99.39%
-2.27 MCAD-5.01%
-2.39 MCAD-37.54%
-3.83 MCAD-15.99%
-4.56 MCAD+54.31%
-2.96 MCAD-1.43%
-3.00 MCAD-24.84%
-3.99 MCAD+185.06%
-1.40 MCAD+24.46%
-1.12 MCAD+74.80%
-643,209.00CAD+24.91%
-514,950.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medx Health Stock analysis

What does Medx Health do? Medx Health Corp, trading under the ticker MDX.V, is a Canadian company headquartered in Mississauga, Ontario. The company went public on February 12, 2008, and operates within the Health Care sector, specifically in the Health Care industry. Medx Health Corp develops, manufactures, and sells medical devices and software. Its primary focus is on skin health, utilizing SIAscopy technology for skin-related screening tools. The company offers a telemedicine platform called SIAscopy on DermSecure, which integrates its SIAscopy scanning technology for web-based operations. Products include SIAMETRICS, SIMSYS, and MoleMate, which are hand-held devices that use light-based technology to examine moles and lesions up to two millimeters beneath the skin surface in a pain-free, non-invasive manner. These devices are designed for the rehabilitation market, providing phototherapy treatments using low-level laser and light-emitting diode technology to address pain and tissue damage. The company's offerings are centered around non-invasive skin screening and phototherapeutic applications, targeting both diagnostic and therapeutic needs within the health care sector. Medx Health Corp's products are intended for medical professionals and patients seeking advanced, non-invasive solutions for skin health management and rehabilitation. Medx Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medx Health stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medx Health is -4.53 M CAD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Medx Health changed from -2.27 M CAD to -4.53 M CAD, representing a 99.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Medx Health since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Medx Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Medx Health

All Key Metrics — Medx Health